|
Bioxyne Launches BLS Clinics - Online Healthcare
|
13 June 2023 at 9:30am
|
|
Becoming a substantial holder
|
8 June 2023 at 5:05pm
|
|
Becoming a substantial holder
|
31 May 2023 at 6:00pm
|
|
Change in substantial holding
|
31 May 2023 at 5:50pm
|
|
Notification regarding unquoted securities - BXN
|
25 May 2023 at 9:45am
|
|
Ceasing to be a substantial holder X 2
|
23 May 2023 at 5:10pm
|
|
Becoming a substantial holder
|
23 May 2023 at 5:10pm
|
|
Becoming a substantial holder
|
23 May 2023 at 5:10pm
|
|
Final Directors Interest Notice X 2
|
23 May 2023 at 1:10pm
|
|
Initial Directors Interest Notice X 2
|
23 May 2023 at 1:10pm
|
|
Cleansing Notice
|
22 May 2023 at 6:50pm
|
|
Application for quotation of securities - BXN
|
22 May 2023 at 6:30pm
|
|
Application for quotation of securities - BXN
|
22 May 2023 at 6:20pm
|
|
Bioxyne Completes Acquisition of Breathe Life Sciences
|
22 May 2023 at 11:50am
|
|
Results of Meeting
|
5 May 2023 at 4:40pm
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
24 April 2023 at 2:45pm
|
|
Letter to Shareholders re Notice of Meeting
|
6 April 2023 at 9:40am
|
|
Notice of Meeting Proxy Form Independent Experts Report
|
6 April 2023 at 9:25am
|
|
Bioxyne Executes SPA to Acquire Breathe Life Sciences
|
20 March 2023 at 8:55am
|
|
Becoming a substantial holder
|
27 February 2023 at 11:25am
|
|
Half Yearly Report and Accounts
|
23 February 2023 at 4:50pm
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
27 January 2023 at 9:00am
|
|
BXN to Acquire Health & Wellness Co Breathe Life Sciences
|
19 December 2022 at 9:15am
|
|
New Constitution
|
30 November 2022 at 8:50pm
|
|
Results of Meeting
|
28 November 2022 at 4:15pm
|
|
Cleansing Notice
|
16 November 2022 at 11:40am
|
|
Application for quotation of securities - BXN
|
16 November 2022 at 10:55am
|
|
Proposed issue of securities - BXN
|
15 November 2022 at 6:15pm
|
|
Notification of cessation of securities - BXN
|
3 November 2022 at 9:25am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 October 2022 at 8:35am
|
|
Letter to Shareholders on Annual General Meeting Notice
|
28 October 2022 at 5:50pm
|
|
Notice of Annual General Meeting/Proxy Form
|
28 October 2022 at 5:50pm
|
|
Cleansing Notice
|
26 October 2022 at 9:10am
|
|
Application for quotation of securities - BXN
|
26 October 2022 at 9:05am
|
|
Proposed issue of securities - BXN
|
25 October 2022 at 10:20am
|
|
Joins Asian Partner & Sells 49% of Direct Selling Business
|
24 October 2022 at 8:50am
|
|
AGM Date and Closing Date for Director Nominations
|
4 October 2022 at 3:10pm
|
|
Appendix 4G and Corporate Governance Statement
|
30 September 2022 at 12:59pm
|
|
Annual Report to shareholders
|
30 September 2022 at 12:40pm
|
|
Preliminary Final Report
|
30 August 2022 at 10:15am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 July 2022 at 8:55am
|
|
Initial Director's Interest Notice
|
30 June 2022 at 5:40pm
|
|
Final Director's Interest Notice
|
30 June 2022 at 5:40pm
|
|
Board and Management Changes
|
8 June 2022 at 9:20am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 April 2022 at 8:45am
|
|
Change of Director's Interest Notice
|
22 March 2022 at 7:30pm
|
|
Appendix 4D and Interim Report
|
22 February 2022 at 12:05pm
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 January 2022 at 9:15am
|
|
Results of Meeting
|
30 November 2021 at 12:40pm
|
|
Reinstatement to Official Quotation
|
4 November 2021 at 9:15am
|
Bioxyne